Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3H2101
Thu, 20.07.2023
aap Implantate AG
With regard to its innovative antibacterial silver coating technology, aap was able to successfully resume recruitment in the ongoing human clinical trial with an adapted study design and achieve a significant acceleration in patient recruitment after only a short time with the new study protocol.
Currently, aap expects patient recruitment to be [ … ]
Thu, 20.07.2023
aap Implantate AG
With regard to its innovative antibacterial silver coating technology, aap was able to successfully resume recruitment in the ongoing human clinical trial with an adapted study design and achieve a significant acceleration in patient recruitment after only a short time with the new study protocol.
Currently, aap expects patient recruitment to be [ … ]
Tue, 18.07.2023
aap Implantate AG
Sales Q2: EUR 2.9 million (+8 % yoy); LATAM (+13 % yoy), USA (+7 % yoy) and EMEA (+6 % yoy, resulting from growth in Germany).
Revenue half-year 2023: EUR 5.9 million (+6 % yoy); LATAM (+29 % yoy) and USA (+11 % yoy) with significant double-digit growth; EMEA at -3 % yoy, recovery trend after Q1 due to upturn in Q2.
aap Implantate AG ("aap" or th [ … ]
Tue, 18.07.2023
aap Implantate AG
Sales Q2: EUR 2.9 million (+8 % yoy); LATAM (+13 % yoy), USA (+7 % yoy) and EMEA (+6 % yoy, resulting from growth in Germany).
Revenue half-year 2023: EUR 5.9 million (+6 % yoy); LATAM (+29 % yoy) and USA (+11 % yoy) with significant double-digit growth; EMEA at -3 % yoy, recovery trend after Q1 due to upturn in Q2.
aap Implantate AG ("aap" or th [ … ]
Wed, 14.06.2023
aap Implantate AG
The Management Board and Supervisory Board of aap Implantate AG ("aap" or the "Company") have, in the run-up to the adoption of the notice convening the Annual General Meeting to be held on July 25, 2023, intensively considered the Company's situation, its future development and the current and assumed macroeconomic environment in the further cours [ … ]
Wed, 14.06.2023
aap Implantate AG
The Management Board and Supervisory Board of aap Implantate AG ("aap" or the "Company") have, in the run-up to the adoption of the notice convening the Annual General Meeting to be held on July 25, 2023, intensively considered the Company's situation, its future development and the current and assumed macroeconomic environment in the further cours [ … ]
Tue, 13.06.2023
aap Implantate AG
The Management Board of aap Implantate AG ("aap" or the "Company") today resolved, with the consent of the Supervisory Board, to propose to the Company's Annual General Meeting to be convened on July 25, 2023, to resolve on the following capital measures:
Reduction of the share capital of the Company from currently EUR 8,955,849.00 by EUR 6,716,88 [ … ]
Tue, 13.06.2023
aap Implantate AG
The Management Board of aap Implantate AG ("aap" or the "Company") today resolved, with the consent of the Supervisory Board, to propose to the Company's Annual General Meeting to be convened on July 25, 2023, to resolve on the following capital measures:
Reduction of the share capital of the Company from currently EUR 8,955,849.00 by EUR 6,716,88 [ … ]
Thu, 25.05.2023
aap Implantate AG
CFO Marek Hahn recently informed the company of his wish not to accept the offered contract extension and to terminate his Executive Board activities as of Dec. 31, 2023
Dr. Nathalie Krebs, Chairwoman of the Supervisory Board, praises Hahn's "dedication, strategic clarity and leadership"
CEO Rubino di Girolamo and COO Agnieszka Mierzejewska wi [ … ]
Thu, 25.05.2023
aap Implantate AG
CFO Marek Hahn recently informed the company of his wish not to accept the offered contract extension and to terminate his Executive Board activities as of Dec. 31, 2023
Dr. Nathalie Krebs, Chairwoman of the Supervisory Board, praises Hahn's "dedication, strategic clarity and leadership"
CEO Rubino di Girolamo and COO Agnieszka Mierzejewska wi [ … ]